The Assessment of TCI633 Probiotics on Pain Relief and Functional Improvement in Osteoarthritis

NCT04267432 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2020-02-12

No results posted yet for this study

Summary

To assess TCI633 probiotics on pain relief and functional improvement in osteoarthritis

Conditions

Interventions

DIETARY_SUPPLEMENT

Placebo

Blank

DIETARY_SUPPLEMENT

TCI633

Probiotics

DRUG

Type 2 collagen

Positive control group

Sponsors & Collaborators

  • TCI Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Ting-Ming Wang, Doctor · National Taiwan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
FACTORIAL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-28
Primary Completion
2019-06-12
Completion
2019-06-12

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04267432 on ClinicalTrials.gov